BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 14610609)

  • 1. The cardiovascular consequences of HIV and antiretroviral therapy.
    Venter WD; Sanne IM
    Cardiovasc J S Afr; 2003; 14(5):225-9. PubMed ID: 14610609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular disease and toxicities related to HIV infection and its therapies.
    Zareba KM; Miller TL; Lipshultz SE
    Expert Opin Drug Saf; 2005 Nov; 4(6):1017-25. PubMed ID: 16255661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metabolic disorders associated with HIV and antiretroviral therapy].
    Roca B
    An Med Interna; 2003 Nov; 20(11):585-93. PubMed ID: 14624657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persons with HIV/AIDS face downside of living longer.
    AIDS Read; 2008 Mar; 18(3):C2. PubMed ID: 18401874
    [No Abstract]   [Full Text] [Related]  

  • 5. Dyslipidaemia and cardiovascular risk in HIV infection.
    Kulasekaram R; Peters BS; Wierzbicki AS
    Curr Med Res Opin; 2005 Nov; 21(11):1717-25. PubMed ID: 16307691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interactions of cardiac and antiretroviral medication].
    Egger S; Drewe J
    Herz; 2005 Sep; 30(6):493-503. PubMed ID: 16170680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long-term consequences of antiretroviral therapy: a review.
    Boyd M; Reiss P
    J HIV Ther; 2006 Jun; 11(2):26-35. PubMed ID: 16981593
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnosis and management of common chronic metabolic complications in HIV-infected patients.
    Bader MS; Kelly DV
    Postgrad Med; 2008 Nov; 120(4):17-27. PubMed ID: 19020362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease.
    Anuurad E; Semrad A; Berglund L
    Metab Syndr Relat Disord; 2009 Oct; 7(5):401-10. PubMed ID: 19355810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease prevention and treatment in patients with human immunodeficiency virus.
    Magen E; Elbirt D; Sthoeger Z
    Isr Med Assoc J; 2005 Apr; 7(4):252-6. PubMed ID: 15847207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolic disorders and cardiovascular risk factors observed in patients infected by the HIV with antiretroviral therapy in Burkina Faso].
    Bognounou R; Diendéré A; Diallo I; Tieno H; Guira O; Ouedraogo DD; Drabo YJ
    Med Trop (Mars); 2011 Dec; 71(6):626-7. PubMed ID: 22393637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating and managing cardiovascular disease risk factors in HIV-infected patients.
    Top HIV Med; 2010 Dec; 18(5):164-8. PubMed ID: 21245517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular involvements in HIV-infected patients.
    Alharethi R
    Expert Rev Cardiovasc Ther; 2013 Sep; 11(9):1227-35. PubMed ID: 23972010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metabolic side effects of antiretroviral therapy].
    van der Valk M; Reiss P
    Ned Tijdschr Geneeskd; 2008 May; 152(22):1260-4. PubMed ID: 18590059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicities of antiretroviral therapy in children.
    Nwaobasi E; Oleske JM
    AIDS Read; 2006 Oct; 16(10):537-40, 544-6,549-50, 552-4. PubMed ID: 17096472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic and morphologic complications of HIV infection.
    Eid AJ; Orenstein R
    J Med Liban; 2006; 54(2):97-105. PubMed ID: 17087001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic complications in HIV infection. In search of underlying mechanisms.
    Johnson DL
    Adv Nurse Pract; 2002 Jul; 10(7):45-50, 76. PubMed ID: 12420551
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular risk and body-fat abnormalities in HIV-infected adults.
    Grinspoon S; Carr A
    N Engl J Med; 2005 Jan; 352(1):48-62. PubMed ID: 15635112
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors.
    Boccara F
    AIDS; 2008 Sep; 22 Suppl 3():S19-26. PubMed ID: 18845918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.